Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR Augmentation in MDD
NCT00892463Phase 4Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- May 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in major depressive disorder (MDD), sponsored by Sunnybrook Health Sciences Centre. Started May 2009; status: completed.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00892463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00892463.